Correlation Between Elevation Oncology and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Cns Pharmaceuticals, you can compare the effects of market volatilities on Elevation Oncology and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Cns Pharmaceuticals.
Diversification Opportunities for Elevation Oncology and Cns Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Elevation and Cns is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Elevation Oncology and Cns Pharmaceuticals
Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.63 times more return on investment than Cns Pharmaceuticals. However, Elevation Oncology is 1.58 times less risky than Cns Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 383.00 in Elevation Oncology on August 24, 2024 and sell it today you would lose (322.00) from holding Elevation Oncology or give up 84.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Elevation Oncology vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Elevation Oncology |
| Cns Pharmaceuticals |
Elevation Oncology and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and Cns Pharmaceuticals
The main advantage of trading using opposite Elevation Oncology and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |